JP2004509063A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509063A5
JP2004509063A5 JP2001576759A JP2001576759A JP2004509063A5 JP 2004509063 A5 JP2004509063 A5 JP 2004509063A5 JP 2001576759 A JP2001576759 A JP 2001576759A JP 2001576759 A JP2001576759 A JP 2001576759A JP 2004509063 A5 JP2004509063 A5 JP 2004509063A5
Authority
JP
Japan
Prior art keywords
amino
prepared
acid
ethylsulfanyl
desired product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001576759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004509063A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/012274 external-priority patent/WO2001079157A1/en
Publication of JP2004509063A publication Critical patent/JP2004509063A/ja
Publication of JP2004509063A5 publication Critical patent/JP2004509063A5/ja
Pending legal-status Critical Current

Links

JP2001576759A 2000-04-14 2001-04-13 ヒドラジンおよびアルコキサミドの血管形成阻害剤 Pending JP2004509063A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54999500A 2000-04-14 2000-04-14
US81300801A 2001-03-21 2001-03-21
PCT/US2001/012274 WO2001079157A1 (en) 2000-04-14 2001-04-13 Hydrazide and alkoxyamide angiogenesis inhibitors

Publications (2)

Publication Number Publication Date
JP2004509063A JP2004509063A (ja) 2004-03-25
JP2004509063A5 true JP2004509063A5 (https=) 2008-03-06

Family

ID=27069307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001576759A Pending JP2004509063A (ja) 2000-04-14 2001-04-13 ヒドラジンおよびアルコキサミドの血管形成阻害剤

Country Status (16)

Country Link
EP (1) EP1272456B1 (https=)
JP (1) JP2004509063A (https=)
AR (1) AR028537A1 (https=)
AT (1) ATE280753T1 (https=)
AU (1) AU2001251631A1 (https=)
BR (1) BR0107204A (https=)
CA (1) CA2406442A1 (https=)
DE (1) DE60106740T2 (https=)
DK (1) DK1272456T3 (https=)
ES (1) ES2231475T3 (https=)
HK (1) HK1053825B (https=)
MX (1) MXPA02010082A (https=)
PE (1) PE20011222A1 (https=)
PT (1) PT1272456E (https=)
UY (1) UY26664A1 (https=)
WO (1) WO2001079157A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05001467A (es) * 2002-08-06 2005-06-03 Abbott Lab Acidos 3-amino-2-hidroxialcanoicos y sus profarmacos.
US8609881B2 (en) * 2008-05-07 2013-12-17 Henkel IP US LCC Cure accelerators for anaerobic curable compositions
DE102008027574A1 (de) 2008-06-10 2009-12-17 Merck Patent Gmbh Neue Pyrrolidinderivate als MetAP-2 Inhibitoren
DE102009005193A1 (de) 2009-01-20 2010-07-22 Merck Patent Gmbh Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren
DE102010048374A1 (de) 2010-10-13 2012-04-19 Merck Patent Gmbh Pyrrolidinone als MetAP-2 Inhibitoren
DE102012006884A1 (de) 2012-04-04 2013-10-10 Merck Patent Gmbh Cyclische Amide als MetAP-2 Inhibitoren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977408A (en) * 1996-10-16 1999-11-02 American Cyanamid Company Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
WO1999042436A1 (en) * 1998-02-19 1999-08-26 American Cyanamid Company N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
DE19831710A1 (de) * 1998-07-15 2000-01-20 Merck Patent Gmbh Diacylhydrazinderivate

Similar Documents

Publication Publication Date Title
DK1446380T3 (da) Formoteroltartrafremgangsmåde og polymorf
CA2360303A1 (en) Process for the preparation of pure citalopram
JP2003531157A5 (https=)
JP2000198797A (ja) 殺菌活性の高いジペプチド化合物および農作物へのそれらの使用
CA2449729A1 (en) Prodrugs of gaba analogs, compositions and uses thereof
AR032671A1 (es) Succinato novedoso de la o-desmetilvenlafaxina
DK1082293T3 (da) Formoterol-polymorfer
CN1036882A (zh) 协同杀菌组合物
WO2004080376A3 (en) Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease
JP2005504782A5 (https=)
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
JP2004509063A5 (https=)
EA200501615A1 (ru) (2-гидрокси-2-(4-гидрокси-3-гидроксиметилфенил)этиламино)пропилфенильные производные в качестве бета-2-агонистов
DK1500390T3 (da) Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
WO2005000243A3 (en) The polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butryric acid
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
WO2024023267A3 (en) Nucleic acid compounds
MY139382A (en) New derivatives of artemisinin , and their uses in the treatment of malaria
JP2005526695A5 (https=)
SE0102641D0 (sv) Novel compounds
NO20042871L (no) Sitronsyre-salt av en terapeutisk forbindelse og farmasoytiske blandinger derav
RU2004124844A (ru) Прукалоприд-n-оксид
EA200700332A1 (ru) Новые полиморфы атовахона и способ их получения
SE0102640D0 (sv) Novel compounds
WO2006089708A8 (en) Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride